Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: Elan | Rare Historical Photos

Insiders Are Betting Big on These 3 Healthcare Stocks

Insiders are buying shares of Braveheart Bio, BlossomHill Therapeutics and Elanco, three health care stocks with differing risk profiles, analyst ratings, and pipeline catalysts ahead.

MarketBeat

Elan group ropes in Marriott International to manage upcoming hotel, branded homes in Gurugram

In an exciting development, Elan Group has teamed up with Marriott International to enhance Gurugram's skyline with the upcoming JW Marriott Hotel and JW Marriott Residences. Elan Group will take charge of the development, while Marriott Hotels India is set to manage both properties. This strategic alliance is geared towards…

The Economic Times

Scribe Elan Ultra 6 wheels review: premium road racing wheelset that climbs as well as they roll

An impressive blend of aerodynamics, low weight, and stiffness

Cycling Weekly

From analysis to the latest developments in health,
read the most diverse news in one place.

How Elan Preschool Turned Personalized Learning Into a 40-Year Legacy

Elan Preschool prides itself for an environment built around the idea that children thrive when they are treated as whole individuals instead of standardized learners.

International Business Times

6 Healthcare Stocks With Strong Upward Momentum

Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of underserved healthcare stocks.

Benzinga

Elanco Shares Poised For Upside After Another Quarter Of Outperformance

Elanco Animal Health Incorporated (NYSE:ELAN) reported third-quarter 2025 results on Wednesday, posting adjusted earnings per share of 19 cents, up 46% year over year.

Benzinga

8 Marshalls Essentials That Will Revive Your Wardrobe

Revamp your wardrobe with some budget-friendly picks under $80 at Marshalls. There's no need to splurge to stay trendy and stylish this fall and winter.

GOBankingRates

Read news from The Economist, FT, and more,
with one subscription

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year.

Benzinga

Barker, Butcher and Tinkler win inaugural Equipe 6 Hours encounter

The #40 Lotus Elan driven by Ben Barker, Rory Butcher, and Ben Tinkler secured victory in the first-ever six-hour Equipe Classic Racing endurance event at Donington Park last weekend. The trio was followed home by the similar Elan of John Tordoff, James Dorlin, and Andrew Jordan.

Autosport

Coronel climbs to second in Ryan Motorsport Insurance Autosport National Rankings

Red Bull protege Rocco Coronel is the main improver in the Ryan Motorsport Insurance Autosport National Rankings this week after taking another two Ginetta Junior wins at Oulton Park.

Autosport

Top 3 Health Care Stocks That Could Blast Off In December

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Benzinga

Pfizer Not Eligible To Recover $75 Million From Settlement With SEC

Judge ruled that Pfizer could not recover $75 million left over from insider trading SEC settlement.

International Business Times

3 Top-Rated Pharma Stocks to Diversify Your Portfolio

The pharmaceutical industry is expanding owing to the rising incidence of chronic diseases, increasing investments in R&D, and the use of advanced technologies for drug development and manufacturing. Given this backdrop, investors could consider buying quality pharma stocks such as Elanco Animal Health (ELAN), Viatris (VTRS), and Astellas Pharma (ALPMY),…

StockNews.com

The Hindu Future India Club to hold sports quiz at IIT-Hyderabad

The Hindu FIC is organising a sports quiz at IIT-Hyderabad on March 16 during Elan and nVision fest.

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Should You Buy Shares of Elanco Animal Health on the Dip?

Despite the company’s higher-than-industry average profitability and solid earnings growth prospects, the shares of Elanco Animal Health are trading way below their 52-week price high. So, is it wise to buy the dip in the stock? Read on to learn our view.

Benzinga

Elanco Animal Health Cuts FY22 Guidance After Q1 Earnings Beat Expectations Marginally

Elanco Animal Health Inc (NYSE:ELAN) has reported a Q1 EPS of $0.36, lower than the $0.37 reported a year ago, surpassing analysts' view of $0.35. Revenue was $1.225 billion, a decrease of 1% YY, slightly above the consensus of $1.22 billion. Pet Health's revenue decreased by 1% and was up 2% when excluding…

Benzinga

How To Attend Elanco Animal Health Q1 2022 Earnings Conference Call

Elanco Animal Health (NYSE:ELAN) will host a conference call at 08:00 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. How to Attend Elanco Animal Health (ELAN) Conference Call Follow this link to access the live webcast.

Benzinga

Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm

Elanco Animal Health Incorporated (NYSE:ELAN) and Ginkgo Bioworks Holdings Inc (NYSE:DNA) have launched BiomEdit, a microbiome innovation company. BiomEdit will discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines, and microbial monitoring services for animal health. In October last year, Elanco announced its intention to carve out its microbiome platform and pipeline under the leadership…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Better Buy for 2022: Elanco Animal Health vs. IDEXX Laboratories

Given the unprecedented increase in pet ownership since the onset of the COVID-19 pandemic, rising consumer spending on pet food, medications, and other ancillary pet services has driven the pet care industry’s growth. Because high demand is expected to persist going forward, prominent pet stocks IDEXX Laboratories (IDXX) and Elanco…

Benzinga

Elanco Animal Health's Q4 Earnings Beat Expectation, FY22 Sales Guidance Trail Estimates

Elanco Animal Health Inc (NYSE: ELAN) has reported

Benzinga

Elanco's Long-Acting Transdermal Buprenorphine for Cats Gains FDA Approval

The

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.